Grantham, Mayo, Van Otterloo & Co »

Horizon Therapeutics shares owned by Grantham, Mayo, Van Otterloo & Co

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Grantham, Mayo, Van Otterloo & Co from 13F filings

Historical chart of Grantham, Mayo, Van Otterloo & Co investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Grantham, Mayo, Van Otterloo & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Grantham, Mayo, Van Otterloo & Co

Quarter filed Position value Share count Share price at filing
2023-09-30 $14M 123k 115.69
2023-06-30 $32M 313k 102.85
2023-03-31 $24M 216k 109.14
2022-12-31 $5.0M 44k 113.80

More positions owned by Grantham, Mayo, Van Otterloo & Co

Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Alphabet Cap Stk Cl A (GOOGL)
Johnson & Johnson (JNJ)
Meta Platforms Cl A (META)
Apple (AAPL)
Amazon (AMZN)
Accenture Plc Ireland Shs Class A (ACN)
Oracle Corporation (ORCL)
Lam Research Corporation (LRCX)
Merck & Co (MRK)
Texas Instruments Incorporated (TXN)
Anthem (ELV)
Coca-Cola Company (KO)
TJX Companies (TJX)

View all positions for Grantham, Mayo, Van Otterloo & Co

Top funds holding Horizon Therapeutics

IFP Advisors
Beacon Capital Management
Huntington National Bank

View all funds holding Horizon Therapeutics